Skip to main content


E. Antonio Chiocca, MD, PhD, is the Harvey Cushing Professor of Neurosurgery at Harvard Medical School and is the Chairman Neurosurgery at the Brigham and Women’s Hospital.  He was previously Chairman of the Department of Neurosurgery at the Ohio State University Medical Center.  He has been continuously funded by the NIH since 1996. He has more than 300 peer-reviewed publications, some in journals such as Nature Medicine, Nature Biotechnology, Molecular Cell, and PNAS.  He has elucidated how viruses with specific gene mutations will replicate selectively in tumors with a specific defect in a tumor suppressor pathway. He has also shown how modulation of innate immunity will improve replication of these tumor-selective viruses. He has been PI of severalmulti-institutional clinical trials of gene-, viral-therapies for malignant gliomas, has been permanent member of NIH study sections (NCI DT and NCI P01-D clinical studies), has been a member of the federal recombinant DNA Advisory Committee (RAC/OBA) and a member of the NINDS Scientific Advisory Council.

In 2013, he was elected Vice-President of the Society for Neuro-Oncology (SNO).  In 2015, he was elected President of SNO. He is on the executive leadership of the American Academy of Neurological Surgery and of the Society of Neurological Surgery. He also serves on the scientific advisory board of several foundations (Sontag, American Brain Tumor Association).  He received The Grass Award in 2007, the Farber Award in 2008, the Bittner Award in 2013, and the Joel A. Gingras Award in 2016.  He was elected to the American Society for Clinical Investigation (2005), is an AAAS fellow (2005) and was also elected to the National Academy of Medicine (formerly Institute of Medicine) in 2014.  He also has served on multiple editorial boards and is the current Tumor Section Editor for Neurosurgery and Associate Editor for Neuro-oncology. He was on the editorial board of Journal of Neurosurgery from 2005 until 2012.